Myeloma

I sit on the edge of the chair beside her bed and choose my words with care. The doctor has just shared an update about…

An approved treatment regimen using the oral therapy Zenbexus (iberdomide) can reduce the risk of disease progression among people with hard-to-treat multiple myeloma,…

Do you ever wonder if the myeloma is coming back? It’s often the first question a patient in remission asks when they get…

An arm of the European Medicines Agency (EMA) — which reviews clinical trial data for drugs under regulatory review in the European Union — has…

I am folding laundry in the living room when my mum makes a quiet remark about the weather. For a second, the tone of her…

A new study by U.S. researchers suggests that using high-potency chemotherapy in myeloma as part of bridging therapy — medications given before patients are…

Note: This column describes the author’s own experiences with autologous stem cell transplant. Not everyone will have the same response to treatment. Consult your doctor…

Infections affecting nearly three-quarters of people with myeloma taking part in clinical testing for the now-approved treatment Lynozyfic (linvoseltamab-gcpt) sparked evolving “infection protection”…

I reach for a word that does not exist in ordinary language. My mum has been quiet all morning, not in pain exactly, but carrying…

Adding the experimental anti-CD38 therapy felzartamab reduced the risk of disease progression among people with hard-to-treat myeloma in a Phase 3 clinical trial conducted…